W. David Henner

6.7k citations

95 papers · 5.5k indexed · h-index 43

Impact in

Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment
Oncology top 1%

Papers in

Oncology 47
- Cancer Diagnosis and Treatment 19
- Cancer Treatment and Pharmacology 9
Oral Surgery 10
- Oral and Maxillofacial Pathology 10

Co-authors: Tomasz M. Beer William A. Haseltine Thomas C. Shea Steven M. Grunberg Sidney M. Hecht Barbara J.S. Sanderson Luis O. Rodriguez Myrna Y. Munar
Journals: Journal of Clinical Oncology (14 papers)Biochemistry (6 papers)Cancer (5 papers)Journal of Biological Chemistry (5 papers)Nucleic Acids Research (4 papers)
Partner nations: United States Germany Canada

In The Last Decade

W. David Henner

93 papers receiving 5.3k citations

Peers

Countries citing papers authored by W. David Henner

Since Specialization

Citations

This map shows the geographic impact of W. David Henner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. David Henner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. David Henner more than expected).

Fields of papers citing papers by W. David Henner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. David Henner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. David Henner. The network helps show where W. David Henner may publish in the future.

Co-authors

The 25 scholars most cited alongside W. David Henner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. David Henner Line = papers co-authored together W. David Henner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Multicenter Study Directly Comparing the Diagnostic Accuracy of Gene Expression Profiling and Immunohistochemistry for Primary Site Identification in Metastatic Tumors The American Journal of Surgical Pathology ·Charles R. Handorf, Anand Kulkarni, James P. Grenert, Lawrence M. Weiss, William M. Rogers, Arthur Schuetze, Federico A. Monzon, Meredith Halks‐Miller, Glenda G. Anderson, Michael G. Walker, Raji Pillai, W. David Henner	2013	59
2	Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer Diagnostic Pathology ·Anand Kulkarni, Raji Pillai, Ryan Qomar Alviandy, W. David Henner, Charles R. Handorf	2012	12
3	Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded Specimens Journal of Molecular Diagnostics ·Raji Pillai, Jazmin Zetabobo Molina, C. Ted Rigl, J. Scott Nystrom, Citra Nur Wahyunita, Ljubomir Buturović, W. David Henner	2011	96
4	Unique patterns of metastases in common and rare types of malignancy Journal of Surgical Oncology ·Stanley P. L. Leong, Eric K. Nakakura, Raphael E. Pollock, Michael A. Choti, Donald L. Morton, W. David Henner, Anita Lal, Raji Pillai, Orlo H. Clark, Blake Cady	2011	26
5	Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test Diagnostic Pathology ·Federico A. Monzon, Fabíola Medeiros, Maureen A. Lyons‐Weiler, W. David Henner	2010	48
6	Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer Cancer Chemotherapy and Pharmacology ·Tomasz M. Beer, Milind Javle, Christopher W. Ryan, Mark Garzotto, Gilbert N. Lam, Alvin Wong, W. David Henner, Candace S. Johnson, Donald L. Trump	2006	41
7	Pharmacokinetics (PK) and tolerability of DN-101, a new formulation of calcitriol, in patients with cancer Cancer Research ·Tomasz M. Beer, Milind Javle, W. David Henner, Donald L. Trump	2004	4
8	Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer Cancer Chemotherapy and Pharmacology ·Randall Rago, Albert Einstein, Richard M. Lush, Tomasz M. Beer, Yoo-Joung Ko, W. David Henner, Glenn J. Bubley, Anaïs Luya Schmidt, Varun Garg, Ene Ette, Matthew W. Harding, William S. Dalton	2003	25
9	Polymorphisms of GSTT1 and related genes in head and neck cancer risk Head & Neck ·A. Evans, W. David Henner, 弘子近藤, C Benetatos, Emily M. Wersinger, Peter E. Andersen, James I. Cohen, Edwin C. Everts, J. M. Keynes, Tomasz M. Beer	2003	37
10	Intermittent chemotherapy in metastatic androgen-independent prostate cancer British Journal of Cancer ·Tomasz M. Beer, Mark Garzotto, W. David Henner, 弘子近藤, Emily M. Wersinger	2003	39
11	TLK286-induced activation of the stress response apoptotic signaling pathway Fangfang Meng, Jennifer Coccomo, Gail L. Brown, James Keck, W. David Henner, Association pour la Connaissance des Invertébrés, R.F. Gomez, M. Wick	2002	6
12	A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation. PubMed ·Tomasz M. Beer, Myrna Y. Munar, W. David Henner	2001	105
13	Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer Annals of Oncology ·Tomasz M. Beer, William Pierce, B A Lowe, W. David Henner	2001	162
14	The effect of chemical carcinogenesis on rat glutathione S-transferase P1 gene transcriptional regulation Molecular Biology Reports ·Dongyuan Liu, Mingxiang Liao, Jin Zuo, W. David Henner, Fude Fang	2001	4
15	Dose‐dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells Environmental and Molecular Mutagenesis ·Barbara J.S. Sanderson, Kara Johnson, W. David Henner, T R Skopek	1991	17
16	GST1 gene deletion determined by polymerase chain reaction Nucleic Acids Research ·Kenine E. Comstock, Barbara J.S. Sanderson, Emad H. Soliman, W. David Henner	1990	98
17	Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. PubMed ·Andi Rani Gustia Maharani, Beverly A. Teicher, Thomas C. Shea, Sylvia A. Holden, Kristina W. Rosbe, Antoine Al-Achi, W. David Henner	1989	82
18	A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. Journal of Clinical Oncology ·Thomas C. Shea, Taras Vyacheslavovich Shevchenko, Alby Elias, Márcio Plácido Corrêa, Karen H. Antman, Colin B. Begg, Lowell E. Schnipper, E Frei, W. David Henner	1989	155
19	Cyclophosphamide and Thiotepa With Autologous Bone Marrow Transplantation in Patients With Solid Tumors JNCI Journal of the National Cancer Institute ·Joseph P. Eder, Karen H. Antman, Anthony Elias, Thomas C. Shea, Beverly A. Teicher, W. David Henner, S Schryber, Sylvia A. Holden, Robert W. Finberg, Rohullah Mayar, Mary Flaherty, Rosemarie Mick, Lowell E. Schnipper, Emil Frei	1988	42
20	Glutathione transferase in human tumors M. Tracie Shea, W. David Henner	1986	3

About W. David Henner

W. David Henner is a scholar working on Oncology, Oral Surgery, Pathology and Forensic Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (19 papers), Glutathione Transferases and Polymorphisms (16 papers), Prostate Cancer Treatment and Research (14 papers), DNA and Nucleic Acid Chemistry (11 papers), Tumors and Oncological Cases (11 papers), Oral and Maxillofacial Pathology (10 papers), DNA Repair Mechanisms (9 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.9k citations), Pathology and Forensic Medicine (853 citations), Molecular Biology (2.9k citations) and Hematology (412 citations). W. David Henner has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Tomasz M. Beer, William A. Haseltine, Thomas C. Shea, Steven M. Grunberg, Sidney M. Hecht, Barbara J.S. Sanderson, Luis O. Rodriguez, Myrna Y. Munar, Bruce A. Lowe and Mark Garzotto. Their work appears in journals such as Journal of Clinical Oncology, Biochemistry, Cancer, Journal of Biological Chemistry and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact